https://www.marketscreener.com/quote/stock/GSK-PLC-9590199/news/GlaxoSmithKline-Trelegy-Ellipta-Once-Daily-Single-Inhaler-Triple-Therapy-Gains-Marketing-Authorisa-25515765/?utm_source=telegram&utm_medium=social&utm_campaign=share